Patents by Inventor Lihuai Qin

Lihuai Qin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROBIFUNCTIONAL COMPOUNDS AS DEGRADERS OF ENL
    Publication number: 20230391765
    Abstract: Disclosed are Eleven-Nineteen Leukemia (ENL) degradation/disruption compounds including a ENL ligand, a degradation/disruption tag and a linker, and methods for use of such compounds in the treatment of ENL-mediated diseases.
    Type: Application
    Filed: October 19, 2021
    Publication date: December 7, 2023
    Inventors: Jian Jin, H. Umit Kaniskan, Lihuai Qin, Hong Wen, Xiaobing Shi, Longxia Xu, Zhaoyu Xue
  • SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA
    Publication number: 20230242496
    Abstract: Disclosed are compounds that are chemical inhibitors of SOX11. The compounds disclosed are useful in treatment of various cancers.
    Type: Application
    Filed: June 15, 2021
    Publication date: August 3, 2023
    Applicant: Icahn School of Medicine At Mount Sinai
    Inventors: Jian JIN, Marta FILIZOLA, Aneel AGGARWAL, Samir PAREKH, Abhijeet KAPOOR, Shashidhar S. JATIANI, H. Umit KANISKAN, Jianping HU, Yudao SHEN, Fanye MENG, Lihuai QIN, Yulin HAN, Xufen YU, Chengwei ZHANG, Prashasti KUMAR, Rinku JAIN, Clement LEE